Key messages: Recent breakthroughs in behavioral science demonstrate that people make decisions, including treatment adherence decisions, according to two systems of thinking: System 1, which is rapid but intuitive and biased, and System 2, which is more rational and reflective but complex. Humans tend to favor System 1. Both System 1 and System 2 lead…
Key messages: The human mind has evolved to make decisions and draw the most plausible conclusions regardless of the quality of available information. The decision-making process is influenced by heuristics, or cognitive shortcuts, which can have a significant effect on adherence when relevant information is limited. Understanding heuristics can significantly help us understand patients’ adherence…
Key Messages Non-adherence factors may be organized into five categories: socioeconomic, health care team and system-related, disease-related, therapy-related, and patient-related. Behavioral drivers of non-adherence are both intentional and unintentional. Despite extensive research, no single model has yet been shown to be highly accurate in predicting patient adherence. Treatment adherence offers a significant opportunity for improved…
Key Messages Medication non-adherence is widespread and annual cost estimates for developed countries total $290 billion in the US and €1.25 billion in Europe. Vertigo is a significant burden for patients and providers alike, particularly because patients tend to seek emergency care when symptoms are acute. Small improvements in adherence could significantly improve symptom management and reduce…
Key Messages The rapid increase in vertigo disease determinants such as ageing are transforming healthcare needs in developing countries. Medications are effective disease management solutions, but low treatment adherence is widespread. Non-adherence rates reflect a significant opportunity to improve vertigo treatment outcomes in developing countries. Physicians can use a number of simple and efficient strategies…